House lines up biotech lollipops as support grows for an epic 21st Century Cures Act
From the article:
According to Kaiser Health News, more than 1,400 lobbyists have taken a crack — for and against — various sections of this bill. And that helps explain why this compromise bill weighs in at an epic 944 pages.
Rachel Sachs, a professor at Washington University who’s been following this bill closely, notes that some of the original goodies for drug and device makers have been removed, including one section that would have allowed developers to circumvent the FDA’s approval process.
Read the full article here.bioethics fda health care reform health law policy pharmaceuticals rachel sachs regulation